Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism

Anita De Rossi, Marcella Pasti, Fabrizio Mammano, Marina Panozzo, Monica Dettin, Carlo Di Bello, Luigi Chieco-Bianchi

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The principal neutralizing domain (PND) of Human Immunodeficiency Virus type 1 (HIV-1) is mapped to a 24-amino acid sequence located in the hypervariable V3 region of the viral envelope protein. The PND of HIV-1 isolates from infected individuals corresponds mostly to that of the HIV-1 MN strain. We found that a peptide designed from the PND of HIV-1 MN virus greatly enhanced viral infection, while a peptide-derived PND of HTLV-IIIB virus showed at least 10-fold less efficient activity; no such effect was exhibited by the other peptides tested, including one designed from the PND of HIV-1 RF strain. The observed enhancing effect occurred in the early steps of viral infection and was not strain-restricted as both MN- and IIIB-derived peptides increased heterologous virus expression, including that of the RF strain. The MN- and, to a lesser extent, IIIB-derived peptides also increased CD4 expression on the cell membrane and differentially inhibited CD4 down-regulation induced by the phorbol ester TPA and/or by the monosialoganglioside GM1; the peptides showing no viral infection enhancement had no such effects. These findings demonstrate that the viral enhancement observed took place through a CD4-dependent mechanism and suggest that the PND is involved in HIV-1 infection and spread.

Original languageEnglish
Pages (from-to)187-196
Number of pages10
JournalVirology
Volume184
Issue number1
DOIs
Publication statusPublished - 1991

Fingerprint

Virus Diseases
HIV-1
Peptides
Viral Envelope Proteins
Viruses
Deltaretrovirus
Phorbol Esters
Amino Acid Sequence
Down-Regulation
Cell Membrane

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism. / Rossi, Anita De; Pasti, Marcella; Mammano, Fabrizio; Panozzo, Marina; Dettin, Monica; Bello, Carlo Di; Chieco-Bianchi, Luigi.

In: Virology, Vol. 184, No. 1, 1991, p. 187-196.

Research output: Contribution to journalArticle

Rossi, Anita De ; Pasti, Marcella ; Mammano, Fabrizio ; Panozzo, Marina ; Dettin, Monica ; Bello, Carlo Di ; Chieco-Bianchi, Luigi. / Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism. In: Virology. 1991 ; Vol. 184, No. 1. pp. 187-196.
@article{ac7bbe9cca874af7aef670d5accf9233,
title = "Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism",
abstract = "The principal neutralizing domain (PND) of Human Immunodeficiency Virus type 1 (HIV-1) is mapped to a 24-amino acid sequence located in the hypervariable V3 region of the viral envelope protein. The PND of HIV-1 isolates from infected individuals corresponds mostly to that of the HIV-1 MN strain. We found that a peptide designed from the PND of HIV-1 MN virus greatly enhanced viral infection, while a peptide-derived PND of HTLV-IIIB virus showed at least 10-fold less efficient activity; no such effect was exhibited by the other peptides tested, including one designed from the PND of HIV-1 RF strain. The observed enhancing effect occurred in the early steps of viral infection and was not strain-restricted as both MN- and IIIB-derived peptides increased heterologous virus expression, including that of the RF strain. The MN- and, to a lesser extent, IIIB-derived peptides also increased CD4 expression on the cell membrane and differentially inhibited CD4 down-regulation induced by the phorbol ester TPA and/or by the monosialoganglioside GM1; the peptides showing no viral infection enhancement had no such effects. These findings demonstrate that the viral enhancement observed took place through a CD4-dependent mechanism and suggest that the PND is involved in HIV-1 infection and spread.",
author = "Rossi, {Anita De} and Marcella Pasti and Fabrizio Mammano and Marina Panozzo and Monica Dettin and Bello, {Carlo Di} and Luigi Chieco-Bianchi",
year = "1991",
doi = "10.1016/0042-6822(91)90835-Y",
language = "English",
volume = "184",
pages = "187--196",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism

AU - Rossi, Anita De

AU - Pasti, Marcella

AU - Mammano, Fabrizio

AU - Panozzo, Marina

AU - Dettin, Monica

AU - Bello, Carlo Di

AU - Chieco-Bianchi, Luigi

PY - 1991

Y1 - 1991

N2 - The principal neutralizing domain (PND) of Human Immunodeficiency Virus type 1 (HIV-1) is mapped to a 24-amino acid sequence located in the hypervariable V3 region of the viral envelope protein. The PND of HIV-1 isolates from infected individuals corresponds mostly to that of the HIV-1 MN strain. We found that a peptide designed from the PND of HIV-1 MN virus greatly enhanced viral infection, while a peptide-derived PND of HTLV-IIIB virus showed at least 10-fold less efficient activity; no such effect was exhibited by the other peptides tested, including one designed from the PND of HIV-1 RF strain. The observed enhancing effect occurred in the early steps of viral infection and was not strain-restricted as both MN- and IIIB-derived peptides increased heterologous virus expression, including that of the RF strain. The MN- and, to a lesser extent, IIIB-derived peptides also increased CD4 expression on the cell membrane and differentially inhibited CD4 down-regulation induced by the phorbol ester TPA and/or by the monosialoganglioside GM1; the peptides showing no viral infection enhancement had no such effects. These findings demonstrate that the viral enhancement observed took place through a CD4-dependent mechanism and suggest that the PND is involved in HIV-1 infection and spread.

AB - The principal neutralizing domain (PND) of Human Immunodeficiency Virus type 1 (HIV-1) is mapped to a 24-amino acid sequence located in the hypervariable V3 region of the viral envelope protein. The PND of HIV-1 isolates from infected individuals corresponds mostly to that of the HIV-1 MN strain. We found that a peptide designed from the PND of HIV-1 MN virus greatly enhanced viral infection, while a peptide-derived PND of HTLV-IIIB virus showed at least 10-fold less efficient activity; no such effect was exhibited by the other peptides tested, including one designed from the PND of HIV-1 RF strain. The observed enhancing effect occurred in the early steps of viral infection and was not strain-restricted as both MN- and IIIB-derived peptides increased heterologous virus expression, including that of the RF strain. The MN- and, to a lesser extent, IIIB-derived peptides also increased CD4 expression on the cell membrane and differentially inhibited CD4 down-regulation induced by the phorbol ester TPA and/or by the monosialoganglioside GM1; the peptides showing no viral infection enhancement had no such effects. These findings demonstrate that the viral enhancement observed took place through a CD4-dependent mechanism and suggest that the PND is involved in HIV-1 infection and spread.

UR - http://www.scopus.com/inward/record.url?scp=0025835943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025835943&partnerID=8YFLogxK

U2 - 10.1016/0042-6822(91)90835-Y

DO - 10.1016/0042-6822(91)90835-Y

M3 - Article

C2 - 1871966

AN - SCOPUS:0025835943

VL - 184

SP - 187

EP - 196

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -